Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors. [electronic resource]
Producer: 20121231Description: 689-98 p. digitalISSN:- 1600-0463
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor -- metabolism
- Disease-Free Survival
- Female
- Gastrointestinal Neoplasms -- metabolism
- Gastrointestinal Stromal Tumors -- metabolism
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Retrospective Studies
- Thymosin -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.